BaptistHealth Heart & Vascular Care offers patients access to new technologies years before other regional hospitals. Our team of multidisciplinary physicians represents the complete spectrum of cardiovascular care and is dedicated to providing you and your family with the best treatment.
We provide convenient cardiovascular care throughout Miami-Dade, Broward, Palm Beach and Monroe Counties across our 11 hospitals, specialty physician practices and renowned centers of excellence: Baptist Health Miami Cardiac & Vascular Institute and Christine E. Lynn Heart & Vascular Institute.
Our researchers play a vital role in helping us better understand heart and vascular disease. They participate in a wide variety of clinical trials dedicated to improving treatments that will ultimately lead to better patient outcomes. Learn more about their work and what it means to be involved in a clinical trial.
Palliative care is provided by a team of palliative care doctors, nurses, social workers, and other specialists. They work together with your cardiologist (heart specialist) to give you an extra layer of support.
Palliative care teams are expertly trained to manage symptoms, side effects, and stresses. For example, they may perform highly-effective lymphatic drainage. This is a technique for reducing leg swelling and its associated pain.
Palliative care is also there to guide you and your loved ones through all the distress caused by heart failure. The team will help you navigate the complex health care system. They will keep you, your family and all of your doctors informed, up to date, and on the same page.
Palliative care specialists can help you plan in advance because heart failure episodes can become worse, sudden, and unpredictable. In fact, one of the most important things your palliative care team can do is help you fully discuss your health with your family and other caregivers.
The team will use its communication expertise to help you achieve your personal goals while living with the disease. They understand that every patient and every family is different. The team is there to help you and your family achieve the best possible quality of life as you live with heart failure.
Cardiomyopathies (disease of the heart muscle) are described according to the effect they have on the structure and function of the cardiac (heart) muscle. The main classification is to divide the disease into:
Although in the majority of cases of heart disease in cats the underlying cause is unknown, there are various potential recognised causes, and your vet may need to investigate some of these. Known potential underlying causes include:
In the initial phase of disease, cats may show no signs at all and appear completely normal. In fact a number of cats with cardiomyopathy may never actually develop clinical disease. However, while in some cats progression of the underlying disease is slow, in others it can be quite rapid.
Some early signs of heart disease may be detectable during a clinical examination by your vet, prior to the onset of any overt signs. This is one of the reasons why every cat should be checked at least once a year by a vet (and ideally more often in older cats). Early warning signs that your vet might detect include:
Many cats, especially those in the early stages of the disease, may only have changes in the cardiac muscle that are detected during ultrasound examination of the heart. These cats are clinically silent (or asymptomatic), although many will go on to develop signs later on.
If heart function is significantly impaired by cardiomyopathy, this will lead to heart failure (often called congestive heart failure), where there is compromise to blood flow through the heart and blood output from the heart.
In cats, the most commonly seen sign of heart failure is the development of difficult breathing (dyspnoea) and/or more rapid breathing (tachypnoea). This is generally caused by either a build up of fluid in the chest cavity around the lungs (called a pleural effusion), or due to a build up of fluid within the lungs themselves (called pulmonary oedema).
Along with breathing difficulties, cats may have cold extremities (eg, ears and paws), and may have pale mucous membranes (gums and eyes) suggesting poor circulation. Occasionally the mucous membranes of the mouth and eyes, and even the skin, may show signs of cyanosis (a bluish colour). Coughing is rarely seen in cats with heart disease, although it is quite common in dogs. If coughing is seen in cats, it is more likely to be caused by a disease of the airways (such as bronchitis).
The underlying cause of cardiomyopathy is only rarely treated, however if it develops secondary to taurine deficiency in the diet (which can be a cause of DCM), or secondary to conditions such as hypertension (high blood pressure) or hyperthyroidism (overactive thyroid gland), then treating the underlying disease may improve cardiac function.
Unfortunately the true effectiveness of many drugs in treating heart disease in cats is unknown, and more clinical trials are needed. Different drugs also act in different ways, and so may be helpful in different situations. In general, diuretics are the most useful drugs in managing signs of congestive heart failure,. With early diagnosis of heart disease, treatment may help to slow or delay its progression and help to maintain a good quality of life.
All our advice is freely accessible to everyone, wherever you are in the world. However, as a charity, we need your support to enable us to keep delivering high quality and up to date information for everyone. Please consider making a contribution, big or small, to keep our content free, accurate and relevant.
Your purchase directly supports the leading global cat welfare charity, International Cat Care. They provide cat owners, veterinary professionals and those who live and work with cats the resources, support, and advice they need to better care for cats.
Your treatment for SVT depends on a few things. They include what type of SVT, how often you have episodes, and how severe your symptoms are. The goals of treatment are to prevent episodes, relieve symptoms, and prevent problems. You and your doctor can decide what type of treatment is right for you.
When episodes of SVT start suddenly and cause symptoms, you can try vagal maneuvers. Your doctor will teach you how to do these safely. These are things such as bearing down or putting an ice-cold wet towel on your face. Bearing down means that you try to breathe out with your stomach muscles but you don't let air out of your nose or mouth. Your doctor might recommend that you do these actions while you lie down on your back. Your doctor may also prescribe a short-acting medicine that you can take. This allows some people to manage their SVT mostly at home.
If your heart rate cannot be slowed using vagal maneuvers, you may have to go to your doctor's office or the emergency room, where a fast-acting medicine can be given to slow your heart rate. If the arrhythmia does not stop and symptoms are severe, you may need a procedure called electrical cardioversion to reset your heart rhythm.
If you have recurring episodes of SVT, you may need to take medicines, either on an as-needed basis or daily. Medicine treatment may include beta-blockers, calcium channel blockers, or other antiarrhythmic medicines. In people who have frequent episodes, treatment with medicines can decrease how often these occur. But these medicines may have side effects.
Many people with SVT have a procedure called catheter ablation. This procedure can stop the rhythm problem in most people. During this procedure, the extra electrical pathway or cells in the heart that are causing the fast heart rate can often be identified and destroyed. Ablation is considered safe. But it has some rare, serious risks.
An electric shock to the heart is called electrical cardioversion. It may be needed if you are having severe symptoms of SVT and your heart rate doesn't go back to normal using vagal maneuvers or fast-acting medicines.
The site is secure.
The ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Background: Although intensively studied in hospital and emergency settings, chest pain has remained largely unstudied in primary care, where it is associated with considerable diagnostic uncertainty and high utilization of medical resources.
Methods: We employed an established primary care research network to prospectively collect detailed information on episodes of care for chest pain. Over a 12-month period, Michigan Research Network (MIRNET) clinicians prospectively collected demographic, clinical, and clinician decision-making information for all patients seen in their offices with the complaint of chest pain.
Results: Three hundred ninety-nine complete episodes were collected and used for analysis. Episodes were well distributed among urban, rural, academic, and private sites. The average episode length was 1.53 visits. Musculoskeletal chest pain accounted for 20.4% of all diagnoses, followed by reflux esophagitis (13.4%) and costochondritis (13.1%). Stable angina pectoris was the primary diagnosis in only 10.3% of episodes, unstable angina or possible myocardial infarction in 1.5%. Most of the ancillary services used were directed toward finding or excluding cardiac disease.
Conclusion: A practice-based network can be used to study episodes of care. Resource use during episodes of chest pain in primary care are directed toward exclusion of cardiac disease, despite the surprisingly low frequency of cardiac diagnoses.
Hospital readmission is just one of many quality targets that cardiologists and Horizon BCBSNJ have agreed to evaluate as part of the heart failure EOC. The number of emergency room visits and adherence to clinical guidelines, for example, also play a part in determining whether participating doctors have reached the quality goals for each cardiac episode.
3a8082e126